Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS)

NCT06660732 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06660732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06660732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS)
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Recruiting
Start date
March 5, 2025
Completion date
March 31, 2027
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac sarcoidosis